Impella versus VA-ECMO for the treatment of patients with cardiogenic shock: the Impella Network Project - observational study protocol for cost-effectiveness and budget impact analyses.

ABSTRACT:

Introduction

The treatment of patients with cardiogenic shock (CS) encompasses several health technologies including Impella pumps and venoarterial extracorporeal membrane oxygenation (VA-ECMO). However, while they are widely used in clinical practice, information on resource use and quality of life (QoL) associated with these devices is scarce. The aim of this study is, therefore, to collect and comparatively assess clinical and socioeconomic data of Impella versus VA-ECMO for the treatment of patients with severe CS, to ultimately conduct both a cost-effectiveness (CEA) and budget impact (BIA) analyses.

Methods and analysis

This is a prospective plus retrospective, multicentre study conducted under the scientific coordination of the Center for Research on Health and Social

SUBMITTER: Ardito V 

PROVIDER: S-EPMC11216050 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature